Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 15546137)

1.

Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma.

Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash S, Kuick R, Merajver SD, Teknos TN.

Cancer. 2004 Dec 15;101(12):2779-87.

3.

Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.

Capote-Moreno A, Naval L, Muñoz-Guerra MF, Sastre J, Rodríguez-Campo FJ.

J Oral Maxillofac Surg. 2010 Feb;68(2):268-75. doi: 10.1016/j.joms.2009.09.071.

PMID:
20116694
4.

Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma.

Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK, Hanash S.

Arch Otolaryngol Head Neck Surg. 2004 Mar;130(3):295-302.

PMID:
15023835
5.

Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.

Huber GF, Fritzsche FR, Züllig L, Storz M, Graf N, Haerle SK, Jochum W, Stoeckli SJ, Moch H.

Int J Cancer. 2011 Sep 15;129(6):1404-9. doi: 10.1002/ijc.25795. Epub 2011 Feb 11.

PMID:
21105028
6.

The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.

O'Brien CJ, Traynor SJ, McNeil E, McMahon JD, Chaplin JM.

Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):360-5.

PMID:
10722009
7.

The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas.

Wenzel S, Sagowski C, Kehrl W, Metternich FU.

Eur Arch Otorhinolaryngol. 2004 May;261(5):270-5. Epub 2003 Sep 18.

PMID:
14504863
8.

Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.

Tsujikawa T, Yaguchi T, Ohmura G, Ohta S, Kobayashi A, Kawamura N, Fujita T, Nakano H, Shimada T, Takahashi T, Nakao R, Yanagisawa A, Hisa Y, Kawakami Y.

Int J Cancer. 2013 Jun 15;132(12):2755-66. doi: 10.1002/ijc.27966. Epub 2012 Dec 17.

PMID:
23180648
9.

CD44 variant isoforms in head and neck squamous cell carcinoma progression.

Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY.

Laryngoscope. 2009 Aug;119(8):1518-30. doi: 10.1002/lary.20506.

10.

Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications.

Wang S, Sun M, Gu C, Wang X, Chen D, Zhao E, Jiao X, Zheng J.

Eur J Oral Sci. 2014 Jun;122(3):202-9. doi: 10.1111/eos.12131. Epub 2014 May 3.

PMID:
24796206
11.

Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx.

Huber GF, Züllig L, Soltermann A, Roessle M, Graf N, Haerle SK, Studer G, Jochum W, Moch H, Stoeckli SJ.

BMC Cancer. 2011 Jun 3;11:217:1-8. doi: 10.1186/1471-2407-11-217.

12.

Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.

Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S.

Am J Gastroenterol. 2004 Sep;99(9):1667-74.

PMID:
15330899
13.

Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.

Fujii N, Shomori K, Shiomi T, Nakabayashi M, Takeda C, Ryoke K, Ito H.

J Oral Pathol Med. 2012 Jul;41(6):444-51. doi: 10.1111/j.1600-0714.2012.01127.x. Epub 2012 Feb 2.

PMID:
22296275
14.

Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.

Huang SF, Wei FC, Liao CT, Wang HM, Lin CY, Lo S, Huang JJ, Chen IH, Kang CJ, Chien HT, Chen HH.

Ann Surg Oncol. 2012 Nov;19(12):3856-64. doi: 10.1245/s10434-012-2392-5. Epub 2012 May 11.

PMID:
22576068
15.

The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer.

Ross G, Shoaib T, Soutar DS, Camilleri IG, Gray HW, Bessent RG, Robertson AG, MacDonald DG.

Arch Otolaryngol Head Neck Surg. 2002 Nov;128(11):1287-91.

PMID:
12431172
16.

Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma.

Costa NL, Valadares MC, Souza PP, Mendonça EF, Oliveira JC, Silva TA, Batista AC.

Oral Oncol. 2013 Mar;49(3):216-23. doi: 10.1016/j.oraloncology.2012.09.012. Epub 2012 Oct 22.

PMID:
23089461
17.

[Comparison of urokinase type plasminogen activators (uPA) and plasminogen activator inhibitors (PAI-1) in primary resection of oral squamous cell carcinoma].

Hundsdorfer B, Zeilhofer HF, Bock KP, Dettmar P, Schmitt M, Horch HH.

Mund Kiefer Gesichtschir. 2004 May;8(3):180-90. Epub 2004 Feb 6. German.

PMID:
15138856
18.

Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.

Marioni G, Marino F, Giacomelli L, Staffieri C, Mariuzzi ML, Violino E, De Filippis C.

Acta Otolaryngol. 2006 Jun;126(6):633-9.

PMID:
16720449
19.

Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base.

Rubio Bueno P, Naval Gias L, García Delgado R, Domingo Cebollada J, Díaz González FJ.

Head Neck. 1998 May;20(3):232-9.

PMID:
9570629
20.

Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.

Nieuwenhuis EJ, van der Waal I, Leemans CR, Kummer A, Pijpers R, Castelijns JA, Brakenhoff RH, Snow GB.

Head Neck. 2005 Feb;27(2):150-8.

PMID:
15627261
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk